UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy

Nature communications, 2019-07, Vol.10 (1), p.3236-14, Article 3236

2019

Volltextzugriff (PDF)

The Co‐mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 Fusion‐Driven Cholangiocarcinoma

Hepatology (Baltimore, Md.), 2021-09, Vol.74 (3), p.1357-1370

2021

Volltextzugriff (PDF)

Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer Cells

Gastroenterology (New York, N.Y. 1943), 2016-08, Vol.151 (2), p.338-350.e7

2016

Volltextzugriff (PDF)

Prospects and Challenges for T Cell-Based Therapies of HCC

Cells (Basel, Switzerland), 2021-06, Vol.10 (7), p.1651

2021

Volltextzugriff (PDF)

Generation of focal mutations and large genomic deletions in the pancreas using inducible in vivo genome editing

Carcinogenesis (New York), 2020-05, Vol.41 (3), p.334-344

2020

Volltextzugriff (PDF)

Potent Antitumor Activity of Liposomal Irinotecan in an Organoid- and CRISPR-Cas9-Based Murine Model of Gallbladder Cancer

Cancers, 2019-11, Vol.11 (12), p.1904

2019

Volltextzugriff (PDF)

CD4 and CD8 T lymphocyte interplay in controlling tumor growth

Cellular and molecular life sciences : CMLS, 2018-02, Vol.75 (4), p.689-713

2018

Volltextzugriff (PDF)

PD-1/CTLA-4 Blockade Leads to Expansion of CD8+PD-1int TILs and Results in Tumor Remission in Experimental Liver Cancer

Liver cancer (Basel ), 2023-06, Vol.12 (2), p.129-144

2023

Volltextzugriff (PDF)

Murine Liver Organoids as a Genetically Flexible System to Study Liver Cancer In Vivo and In Vitro

Hepatology communications, 2019-03, Vol.3 (3), p.423-436

2019

Volltextzugriff (PDF)

Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1

Cancer research (Chicago, Ill.), 2005-08, Vol.65 (16), p.7393-7402

2005

Volltextzugriff (PDF)

Virus infections in tumors pave the way for tumor-directed DC-vaccines

Oncoimmunology, 2012-03, Vol.1 (2), p.208-210

2012

Volltextzugriff (PDF)

Senescence surveillance of pre-malignant hepatocytes limits liver cancer development

Nature (London), 2011-11, Vol.479 (7374), p.547-551

2011

Volltextzugriff (PDF)

Transcriptome Profiling Identifies TIGIT as a Marker of T‐Cell Exhaustion in Liver Cancer

Hepatology (Baltimore, Md.), 2021-04, Vol.73 (4), p.1399-1418

2021

Volltextzugriff (PDF)

Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses

Molecular therapy, 2015-10, Vol.23 (10), p.1630-1640

2015

Volltextzugriff (PDF)

Protein Transduction Domains Fused to Virus Receptors Improve Cellular Virus Uptake and Enhance Oncolysis by Tumor-Specific Replicating Vectors

Journal of Virology, 2004-12, Vol.78 (24), p.13743-13754

2004

Volltextzugriff (PDF)

Tailored Tumor Immunogenicity Reveals Regulation of CD4 and CD8 T Cell Responses against Cancer

Cell reports (Cambridge), 2016-11, Vol.17 (9), p.2234-2246

2016

Volltextzugriff (PDF)

Impending HCC diagnosis in patients with cirrhosis after HCV cure features a natural killer cell signature

Hepatology (Baltimore, Md.), 2024-07, Vol.80 (1), p.202-222

2024

Volltextzugriff (PDF)

Imprint of unconventional T‐cell response in acute hepatitis C persists despite successful early antiviral treatment

European journal of immunology, 2022-03, Vol.52 (3), p.472-483

2022

Volltextzugriff (PDF)

Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic Cancer

Cancer research (Chicago, Ill.), 2018-01, Vol.78 (2), p.475-488

2018

Volltextzugriff (PDF)

Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells

Hepatology (Baltimore, Md.), 2013-08, Vol.58 (2), p.718-728

2013

Volltextzugriff (PDF)

PD-1/CTLA-4 Blockade Leads to Expansion of CD8[sup.+]PD-1[sup.int] TILs and Results in Tumor Remission in Experimental Liver Cancer

Liver cancer (Basel ), 2023-06, Vol.12 (2), p.129

2023

Volltextzugriff (PDF)

CD40 Signaling Drives Potent Cellular Immune Responses in Heterologous Cancer Vaccinations

Cancer research (Chicago, Ill.), 2017-04, Vol.77 (8), p.1918-1926

2017

Volltextzugriff (PDF)

Recombinant LCMV Vectors Induce Protective Immunity following Homologous and Heterologous Vaccinations

Molecular therapy, 2017-11, Vol.25 (11), p.2533-2545

2017

Volltextzugriff (PDF)

ITOC2 – 012. Neoadjuvant immune checkpoint blockade for pancreatic cancer prevents local tumour recurrence through tissue resident antitumoural CD8+ CD103+ T cells

European journal of cancer (1990), 2015-03, Vol.51, p.S4-S5

2015

Volltextzugriff (PDF)

Adjuvant gemcitabine therapy improves survival in a locally induced, R0‐resectable model of metastatic intrahepatic cholangiocarcinoma

Hepatology (Baltimore, Md.), 2013-09, Vol.58 (3), p.1031-1041

2013

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(50)
Buchkapitel
(1)

Sprache

Englisch
(51)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy

The Co‐mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 Fusion‐Driven Cholangiocarcinoma

Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer Cells

Prospects and Challenges for T Cell-Based Therapies of HCC

Generation of focal mutations and large genomic deletions in the pancreas using inducible in vivo genome editing

Potent Antitumor Activity of Liposomal Irinotecan in an Organoid- and CRISPR-Cas9-Based Murine Model of Gallbladder Cancer

CD4 and CD8 T lymphocyte interplay in controlling tumor growth

PD-1/CTLA-4 Blockade Leads to Expansion of CD8+PD-1int TILs and Results in Tumor Remission in Experimental Liver Cancer

Murine Liver Organoids as a Genetically Flexible System to Study Liver Cancer In Vivo and In Vitro

Telomerase-dependent virotherapy overcomes resistance of hepatocellular carcinomas against chemotherapy and tumor necrosis factor-related apoptosis-inducing ligand by elimination of Mcl-1

Virus infections in tumors pave the way for tumor-directed DC-vaccines

Senescence surveillance of pre-malignant hepatocytes limits liver cancer development

Transcriptome Profiling Identifies TIGIT as a Marker of T‐Cell Exhaustion in Liver Cancer

Viral Infection of Tumors Overcomes Resistance to PD-1-immunotherapy by Broadening Neoantigenome-directed T-cell Responses

Protein Transduction Domains Fused to Virus Receptors Improve Cellular Virus Uptake and Enhance Oncolysis by Tumor-Specific Replicating Vectors

Tailored Tumor Immunogenicity Reveals Regulation of CD4 and CD8 T Cell Responses against Cancer

Impending HCC diagnosis in patients with cirrhosis after HCV cure features a natural killer cell signature

Imprint of unconventional T‐cell response in acute hepatitis C persists despite successful early antiviral treatment

Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic Cancer

Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells

PD-1/CTLA-4 Blockade Leads to Expansion of CD8[sup.+]PD-1[sup.int] TILs and Results in Tumor Remission in Experimental Liver Cancer

CD40 Signaling Drives Potent Cellular Immune Responses in Heterologous Cancer Vaccinations

Recombinant LCMV Vectors Induce Protective Immunity following Homologous and Heterologous Vaccinations

ITOC2 – 012. Neoadjuvant immune checkpoint blockade for pancreatic cancer prevents local tumour recurrence through tissue resident antitumoural CD8+ CD103+ T cells

Adjuvant gemcitabine therapy improves survival in a locally induced, R0‐resectable model of metastatic intrahepatic cholangiocarcinoma

Suchergebnisse filtern